Harnessing innate immunity to suppress lymphoma
- PMID: 20697076
- DOI: 10.1200/JCO.2010.30.4212
Harnessing innate immunity to suppress lymphoma
Comment on
-
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.J Clin Oncol. 2010 Oct 1;28(28):4324-32. doi: 10.1200/JCO.2010.28.9793. Epub 2010 Aug 9. J Clin Oncol. 2010. PMID: 20697067 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
